Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH, Leslye M. Heisler assistant professor for lung cancer excellence at the University of Pennsylvania Abramson Cancer Center, spoke with Healio about the treatment and management of non-small cell lung cancer (NSCLC), highlighting areas of unmet need and the benefits of telemedicine in an oncology practice.
In this video, Aggarwal discusses:
- Targeted therapy for NSCLC and its role in treatment regimens for patients with mutations;
- The continued importance of chemotherapy, despite the introduction of targeted therapy;
- Treatment regimens that combine chemotherapy agents and immunotherapy;
- Lack of treatment options and other challenges facing patients with NSCLC who have also had a transplant; and
- How COVID-19 has changed the patient management landscape.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.